Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06765642 · ClinicalTrials.gov registry record · NA

The Effect of Non-invasive Brain Stimulation rTMS on Hand Muscles in Chronic Stroke Patients.

A NA study of Stroke and Transcranial Magnetic Stimulation, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT06765642 is a NA study of Stroke and Transcranial Magnetic Stimulation that is actively recruiting participants, run by Duke University. The registered enrollment target is 26 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06765642, a NA study of Stroke and Transcranial Magnetic Stimulation, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

The study is about using a brain stimulation technique called rTMS (Repetitive Transcranial Magnetic Stimulation) to help improve hand muscles in people who had a stroke. Researchers want to understand how this device can help stroke patients use their hands better.

Interventions

  • DIAGNOSTIC_TEST Transcranial Magnetic Stimulation

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2025-06-09
Est. Completion 2027-04-30
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT06765642

The ClinicalTrials.gov registry entry for NCT06765642 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.

NCT06765642 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06765642 about?

NCT06765642 is a clinical study titled "The Effect of Non-invasive Brain Stimulation rTMS on Hand Muscles in Chronic Stroke Patients.". The study is about using a brain stimulation technique called rTMS (Repetitive Transcranial Magnetic Stimulation) to help improve hand muscles in people who had a stroke. Researchers want to understand how this device can help stroke patients use their hands better.

What is the current status of trial NCT06765642?

This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2025-06-09. Estimated completion is 2027-04-30.

What conditions does trial NCT06765642 study?

This clinical trial studies the following conditions: Stroke, Transcranial Magnetic Stimulation, Chronic Stroke Patients, Stroke Patients, Arm Weakness as a Consequence of Stroke.

What interventions are being tested in trial NCT06765642?

The interventions under investigation include: Transcranial Magnetic Stimulation (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06765642?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06765642 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.